João Vitor Barboza Cardoso | Microbiology | Academic Molecular Biology Award

Published on by Molecular Biologist

Academic Molecular Biology Award

João Vitor Barboza Cardoso
Affiliation UFRGS
Country Brazil
Documents 48
Citations 1,240
h-index 18
Subject Area Microbiology
Event International Molecular Biologist Awards
ORCID
0000-0002-9878-280X

João Vitor Barboza Cardoso
UFRGS, China

João Vitor Barboza Cardoso is a Brazilian researcher affiliated with UFRGS, whose academic contributions in microbiology and molecular biology have been associated with interdisciplinary investigations involving microbial systems, molecular diagnostics, and translational biomedical research. His scientific profile demonstrates continued engagement in scholarly publication, collaborative research, and international academic dissemination within the biological sciences.[2]

Abstract

This article presents an overview of the academic and scientific profile of João Vitor Barboza Cardoso in the field of microbiology and molecular biology. The page summarizes institutional affiliations, research interests, scholarly output, publication impact, and relevance to international scientific recognition programs. The researcher’s contributions reflect active participation in molecular and biomedical investigations involving microbial mechanisms, laboratory methodologies, and translational scientific applications. The academic record demonstrates measurable citation performance and sustained engagement with contemporary microbiological research developments.[1]

Keywords

Microbiology; Molecular Biology; Biomedical Research; Molecular Diagnostics; Translational Science; Scientific Publications; Research Impact; Academic Recognition.

Introduction

Molecular biology and microbiology continue to represent central pillars of modern biomedical and life science research. Advancements in microbial genomics, cellular analysis, and molecular diagnostics have expanded scientific understanding across health, environmental, and translational disciplines. Researchers working in these areas contribute to the interpretation of complex biological systems through experimental methodologies and evidence-based scientific inquiry.[3]

João Vitor Barboza Cardoso has participated in this broader scientific landscape through academic investigations associated with microbiological and molecular approaches. His institutional activities at UFRGS align with the advancement of scientific research, publication dissemination, and collaborative academic engagement within the Brazilian and international research community.[2]

Research Profile

The academic profile of João Vitor Barboza Cardoso reflects sustained scholarly activity in microbiology-related research domains, including molecular characterization, laboratory investigation, and biomedical applications. His research record includes scientific publications indexed in international databases and collaborative studies contributing to contemporary biological science literature.

  • Institutional affiliation with UFRGS and participation in scientific research initiatives.
  • Research engagement within microbiology and molecular biology disciplines.
  • Publication activity in peer-reviewed scientific journals.
  • Citation impact reflecting scholarly visibility and academic dissemination.
  • Participation in interdisciplinary biomedical and molecular investigations.

Research Contributions

The research contributions associated with João Vitor Barboza Cardoso involve molecular and microbiological investigations supporting broader biomedical understanding. His scientific activities demonstrate alignment with evidence-based laboratory analysis, experimental methodologies, and publication dissemination within recognized scientific frameworks.

  1. Development and interpretation of molecular biology methodologies relevant to microbial and biomedical analysis.
  2. Participation in collaborative scientific studies involving microbiological systems and laboratory diagnostics.
  3. Contribution to scientific communication through publication in peer-reviewed journals and indexed databases.
  4. Support for translational biomedical research integrating molecular approaches and applied biological science.

Publications

The publication portfolio associated with João Vitor Barboza Cardoso includes scientific articles addressing microbiological and molecular biological subjects. Indexed publications contribute to academic visibility and demonstrate participation in ongoing scientific discussions within biomedical and life science research.

  • Peer-reviewed publications in microbiology and molecular biology.
  • Research dissemination through international academic databases.
  • Citation-indexed scholarly communication.
  • Scientific contributions linked to translational and laboratory-based biomedical research.

Representative DOI-linked scientific records further demonstrate the researcher’s visibility in indexed scientific ecosystems and digital citation networks.

Research Impact

Research impact indicators provide a measurable framework for evaluating scientific visibility, publication dissemination, and scholarly engagement. Citation metrics, h-index performance, and publication counts collectively reflect the degree to which scientific outputs contribute to ongoing academic discourse.[4]

The academic record attributed to João Vitor Barboza Cardoso demonstrates sustained participation in research communication and citation activity. Such indicators support recognition within academic evaluation frameworks and international award assessment criteria relevant to microbiology and molecular biology.[1]

Award Suitability

The International Molecular Biologist Awards recognize scientific contributions associated with molecular biology, microbiology, translational science, and biomedical innovation. Evaluation criteria commonly include publication quality, citation visibility, academic collaboration, and contributions to advancing scientific understanding within molecular and biological research domains.

Based on the documented academic profile, João Vitor Barboza Cardoso demonstrates characteristics associated with professional research achievement and scientific dissemination. His publication record, institutional affiliation, and research engagement support consideration within academic recognition and scientific distinction frameworks related to microbiology and molecular biology.[5]

Conclusion

João Vitor Barboza Cardoso represents an academic researcher engaged in microbiology and molecular biology through publication activity, collaborative research, and institutional scientific participation. His scholarly profile demonstrates measurable research visibility and contributions aligned with contemporary molecular and biomedical scientific inquiry. Continued research dissemination and interdisciplinary collaboration may further strengthen the long-term impact of his scientific work within the international research community.[1]

References

  1. ORCID. (n.d.). ORCID profile record for João Vitor Barboza Cardoso.
    https://orcid.org/0000-0002-9878-280X
  2. Madigan, M. T., et al. (2018). Brock Biology of Microorganisms. Pearson Education.
    https://doi.org/10.4324/9780429503788
  3. PubMed. (n.d.). Biomedical publication indexing database.
    https://pubmed.ncbi.nlm.nih.gov/
  4. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences.
    https://doi.org/10.1073/pnas.0507655102
  5. International Molecular Biologist Awards. (n.d.). Award evaluation and scientific recognition framework.
    https://molecularbiologist.org/

JEAN MICHEL BRUNEL | Microbiology | Research Excellence Award

Published on by Molecular Biologist

Dr. Jean Michel Brunel | Microbiology | Research Excellence Award

CRHC | Faculty of Pharmacy | France

Dr. Jean Michel Brunel is a distinguished French chemist whose research focuses on organic synthesis, medicinal chemistry, and antimicrobial drug discovery. As a senior CNRS Researcher and group leader at Aix-Marseille Université, he leads a team developing antibiotic adjuvants, polyamine derivatives, and next-generation antimicrobial agents. His work integrates medicinal chemistry, microbiology, and organoselective synthesis to create therapeutic probes and drug prototypes that target bacterial pathways, disrupt biofilms, and enhance antibiotic efficacy against multi-drug-resistant bacteria, including Pseudomonas aeruginosa. Brunel’s research spans natural product chemistry, synthetic scaffolds, and bile acid analogues, extending from in vitro screening to in vivo models to ensure translational impact. Supported by major research grants, international collaborations, and industrial partnerships, his efforts advance the development of innovative anti-infective therapies. His prolific output includes 235 publications cited over 7,700 times across more than 6,200 documents, with an h-index of 42, reflecting his significant influence on global antimicrobial research and drug discovery.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Permeabilize, but choose wisely: Selective antibiotic potentiation through outer membrane disruption in Pseudomonas aeruginosa. International Journal of Molecular Sciences.

Adaptation to cinnamaldehyde shapes Pseudomonas aeruginosa resistance to major antibiotics. Journal of Bacteriology.

Accurate antibiotic accumulation in Enterobacteriaceae isolates expressing efflux pumps. Biochimica et Biophysica Acta Biomembranes.

Don’t miss out on new publications by this author!

Bioinspired syntheses of the marine pyridoacridine alkaloids 2-Bromo and 3-Bromodeoxyamphimedine and structure correction of 2-Bromoamphimedine. Journal of Natural Products.

Efflux-mediated resistance in Enterobacteriaceae: Recent advances and ongoing challenges to inhibit bacterial efflux pumps.

Uric acid, the end-product of purine metabolism, mitigates tau-related abnormalities: Comparison with DOT, a non-antibiotic oxytetracycline derivative. Biomolecules.

 

Ohad Gal-Mor | Microbiology | Best Researcher Award

Published on by Molecular Biologist

Prof. Dr. Ohad Gal-Mor | Microbiology | Best Researcher Award 

Head the Infectious Diseases Research Laboratory | TAU and Sheba Medical Center | Israel

Prof. Dr. Ohad Gal-Mor is a distinguished microbiologist and academic leader specializing in infectious diseases and bacterial pathogenesis. He is Head of the Infectious Diseases Research Laboratory at Sheba Medical Center and a Full Professor in the Department of Clinical Microbiology and Immunology at Tel Aviv University. His research has significantly advanced the understanding of Salmonella virulence, persistence, and host adaptation. He has also contributed to the study of antimicrobial resistance and bacterial evolution, bridging fundamental microbiology with global public health. In addition to his scientific achievements, Prof. Gal-Mor has held influential leadership positions, including Director of the Nehemia Rubin Program for Excellence in Biomedical Research and Chair of the Biomedical Academic Research Institute at Sheba Medical Center. Through his research, teaching, and mentorship, he has shaped the careers of many young scientists and continues to contribute to advancing knowledge in microbiology and infectious diseases worldwide.

Professional Profile

Scopus

ORCID

Google Scholar

Education

Prof. Dr. Ohad Gal-Mor pursued his academic training at Tel Aviv University, where he developed a strong foundation in molecular microbiology and life sciences. He obtained a Bachelor of Science in Biology at the Faculty of Life Sciences, focusing on core areas of biological and molecular systems. Following this, he was accepted into a prestigious direct-track doctoral program, earning his Ph.D. in Molecular Microbiology from the Department of Molecular Microbiology and Biotechnology. His doctoral research was dedicated to exploring microbial genetics and the mechanisms of host-pathogen interactions, providing the groundwork for his later contributions to bacterial pathogenesis. This rigorous training prepared him for postdoctoral research in Canada, where he worked with world-leading scientists and refined his expertise in host-pathogen studies. His educational background reflects both scientific rigor and an interdisciplinary approach, equipping him with the tools to investigate complex questions of microbial evolution, infection biology, and molecular regulation.

Experience

Prof. Dr. Ohad Gal-Mor has an extensive record of academic and research leadership in microbiology. After earning his Ph.D., he pursued postdoctoral research at the University of British Columbia in Canada, focusing on host-pathogen interactions in the laboratory of Professor Brett Finlay. He then advanced to a Research Associate role at the same institution before returning to Israel, where he became Director of the Enterobacteriaceae National Center at the Ministry of Health. Since then, he has established and led the Infectious Diseases Research Laboratory at Sheba Medical Center, driving innovation in infectious disease research. At Tel Aviv University, he progressed from Senior Lecturer to Associate Professor and is now a Full Professor. He has served as Secretary of the Israel Society for Microbiology and Section Editor for the journal Virulence. His professional journey highlights an exceptional blend of academic scholarship, research leadership, and international collaboration.

Research Interests

Prof. Dr. Ohad Gal-Mor’s research focuses on microbial pathogenesis, host-pathogen interactions, and bacterial evolution. His studies primarily investigate Salmonella enterica, with particular emphasis on genetic diversity, antimicrobial resistance, and adaptation to host environments. He explores how horizontally acquired elements, plasmids, and regulatory pathways contribute to virulence and persistence in both human and animal hosts. By integrating molecular biology, microbiology, and genomics, his group uncovers mechanisms that allow bacteria to survive within hosts, evade immune responses, and adapt to different ecological niches. He also investigates the emergence and spread of multidrug-resistant strains, addressing pressing issues in public health. His use of genomic sequencing, transcriptomics, and advanced infection models ensures that his research remains at the forefront of modern microbiology. Ultimately, his work aims to inform the development of novel antimicrobial strategies, vaccines, and prevention approaches, advancing both fundamental science and translational medicine.

Awards and Recognition

Prof. Dr. Ohad Gal-Mor has received recognition for his research excellence and leadership in the field of microbiology. His publication in PLoS Pathogens was highlighted as the Featured Image of the Month and selected as Paper of the Month by the German Society of Hygiene and Microbiology, showcasing his international impact. He has served in leadership roles such as Secretary of the Israel Society for Microbiology and Director of the Nehemia Rubin Program for Excellence in Biomedical Research at Sheba Medical Center, reflecting his dedication to advancing both science and education. His appointment as Chair of the Biomedical Academic Research Institute demonstrates the trust placed in his leadership within Israel’s largest medical center. These honors highlight his contributions not only as a researcher but also as a mentor and leader, recognized nationally and internationally for advancing the study of bacterial pathogenesis and infectious diseases.

Top Noted Publications

Prof. Dr. Ohad Gal-Mor has published extensively in leading international journals, making significant contributions to bacterial pathogenesis and antimicrobial resistance research. Selected publications include:

Title: The transcriptional regulation of the horizontally acquired iron uptake system, yersiniabactin and its contribution to oxidative stress tolerance and pathogenicity of globally emerging salmonella strains.
Journal: Gut Microbes
Year: 2024

Title: Persistent Salmonella infections in humans are associated with mutations in the BarA/SirA regulatory pathway.
Journal: Cell Host & Microbe
Year: 2024

Title: A new Salmonella enterica serovar that was isolated from a wild sparrow presents a distinct genetic, metabolic and virulence profile.
Journal: Microbes and Infection
Year: 2024

Title: The emergence of a multidrug resistant Salmonella Muenchen in Israel is associated with horizontal acquisition of the epidemic pESI plasmid.
Journal: Clinical Microbiology and Infection
Year: 2022

Title: Intracellular Salmonella Paratyphi A is motile and differs in the expression of flagella-chemotaxis, SPI-1 and carbon utilization pathways in comparison to intracellular S. Typhimurium.
Journal: PLoS Pathogens
Year: 2022

Title: The ancestral stringent response potentiator, DksA has been adapted throughout Salmonella evolution to orchestrate the expression of metabolic, motility, and virulence pathways.
Journal: Gut Microbes
Year: 2022

Title: Pathoadaptation of the passerine-associated Salmonella enterica serovar Typhimurium lineage to the avian host.
Journal: PLoS Pathogens
Year: 2021

Title: Emergence of new variants of antibiotic resistance genomic islands among multidrug-resistant Salmonella enterica in poultry.
Journal: Environmental Microbiology
Year: 2020

Title: The plasmid-encoded Ipf and Klf fimbriae display different expression and varying roles in the virulence of Salmonella enterica serovar Infantis in mouse vs. avian hosts.
Journal: PLoS Pathogens
Year: 2017

Conclusion

Prof. Dr. Ohad Gal-Mor stands out as a highly suitable nominee for the Best Researcher Award. His work addresses critical challenges in global health, particularly the rise of antibiotic resistance and the evolution of bacterial pathogens, issues of major concern for both science and society. His scientific rigor, combined with international recognition and leadership, justifies his candidacy as an exemplary researcher whose contributions have advanced the frontiers of microbiology and infectious disease research.